TCF — Theracryf Share News
0.000.00%
Holding(s) in Company
Chronos Integration Update
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company
Director/PDMR Shareholding
Holding(s) in Company
Result of Retail Offer
Retail Offer
Acquisition, Fundraising and Change of Name
SFX-01 positive update in bowel cancer models
Positive update on SFX-01 in vitro GBM studies
Series B Fund Raise by partner, Stalicla SA
Holding(s) in Company
Brief: Evgen Pharma Appoints Toni Hänninen As Permanent CFO
Directorate Changes
Upcoming conferences
Brief: Evgen Pharma HY Post-Tax Loss Of £1.5 Mln